Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Zim Laboratories Limited (NSE: ZIMLAB), ISIN INE518E01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ZIMLAB last traded at ₹133.56 (-0.18%), with a 52-week range of ₹59.72 to ₹144.85 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 30.36%, FIIs 0.03%, DIIs 1.33%, mutual funds 1.07%.
EquiSense Score (ECS): 42/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.